I don’t expect CSCO to shoot up overnight, but it just crossed over its 50DMA and has formed a solid base above $29 so... Read More

Although you don’t normally equate the insurance industry with growth stocks, our Rapids Profits Matrix has identified AmTrust as the type of company that mutual fund legend Peter Lynch... Read More

Sooner or later something has to give for Gilead, and recent share price behavior suggests the protracted dip in its stock price may be turning around. It just... Read More

I am putting the brakes on our position in Delphi Automotive after getting a great ride in this stock, and our 73% annualized gain proves it! Read More

We opened this position five weeks ago ago at an entry price of $22.65, so even though we are selling it short of our target price of $28.00 we will still achieve an annualized return in excess of 100% at today's opening price. Read More

Cintas (CTAS) is a stock that I think is at risk of declining in value soon so the appropriate trade would be either a short sale of the stock or an opening purchase of a long put, but DO NOT GO LONG! Read More

With the next FOMC meeting coming this Tuesday/Wednesday, I am holding off on issuing a new buy alert until after they make an announcement regarding the fed funds rate. I am also bumping up the stop price on DLPH to $69, and on BKE to $25. Read More

We are bailing out of LeMaitre Vascular a month early to protect our gain given recent technical weakness in this stock. We have come close to achieving our target return of 20% on an absolute basis (+17% as of yesterday), and on annualized basis we still have a 100% return in this position so I want to lock that in while we can still have it. Read More